Charles Schoch - 20 Jun 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role: Chief Financial Officer
Signature: /s/ Charles Schoch
Issuer symbol: CADL
Transactions as of: 20 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 24 Jun 2025, 16:30:29 UTC
Previous filing: 19 Mar 2025
Next filing: 26 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Schoch Charles	Chief Financial Officer	C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM	/s/ Charles Schoch	24 Jun 2025	0002007349

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CADL	Stock Option (Right to Buy)	Award	$0	+50,000		$0.000000	50,000	20 Jun 2025	Common Stock	50,000	$4.75	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option is subject to time-based vesting. 25% of the shares underlying this option shall vest and become exercisable on June 20, 2026, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.